Press Release

View printer-friendly version

<< Back

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., March 01, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences:

  • Cowen and Company Annual Health Care Conference 
    Monday, March 6, 2017 at 2:40 p.m. ET  
    Location: Boston, MA

  • Raymond James Annual Institutional Investors Conference 
    Wednesday, March 8, 2017 at 10:25 a.m. ET
    Location: Orlando, FL

  • Barclays Global Healthcare Conference 
    Tuesday, March 14, 2017 at 2:35 p.m. ET
    Location: Miami, FL

To access the live webcasts, please visit the Investors section of the company’s website at www.amagpharma.com. A replay of each event will be archived on the site for 30 days.

About AMAG
AMAG is a biopharmaceutical company focused on developing and delivering important therapeutics, conducting clinical research in areas of unmet need and creating education and support programs for the patients and families we serve. Our currently marketed products support the health of patients in the areas of women's health, anemia management and cancer supportive care. Through CBR®, we also help families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit www.amagpharma.com.

AMAG Pharmaceuticals Contact:
Christi Waarich
Associate Director, Investor Relations
617-498-7638

Primary Logo

AMAG Pharmaceuticals, Inc.